Cancer cells can deploy several strategies to evade immune detection, including: - Downregulation of MHC Class I molecules, making it harder for cytotoxic T cells to recognize tumor antigens. - Expression of immune checkpoint proteins like PD-L1 that inhibit T cell activity. - Production of immunosuppressive cytokines that create a local environment hostile to immune cell function.
